Call for Abstracts open
Abstract submissions are welcome for consideration for the
21st International Vasculitis Workshop,
which will be held in Barcelona, Spain, 7 – 10 April 2024.
Submission deadline extended until December 18th 2023.
The abstract submission process for Vasculitis Workshops 2024 is available through an online submission portal. All abstracts must be submitted exclusively through the online platform before the submission deadline (December 4th 2023).
If you have successfully submitted your abstract, you will receive a confirmation number and an acknowledgement email. If no reference number is received, the abstract cannot be considered as successfully submitted. If you leave the system without finishing the process all data will be lost.
You will be able to modify your submission until the submission deadline. Use the online submission form to access your submission again using the contact-person email address and the password received in the acknowledgement of receipt.
Please contact the scientific secretariat if you have not received the acknowledgement of receipt by email after the submission.
Should you require assistance or have a query regarding online submission, please contact the scientific secretariat at
It is ESSENTIAL that you read the instructions below before you submit.
Submitters will be asked to submit their abstract in the fields of vasculitis and related diseases under one of the following topics in the submission portal:
1. CLINICAL SCIENCE
1.1 Diagnosis and classification: imaging (role in diagnosis, new tracers); pathology...
1.2 Treatment: clinical trials (new trials, post-hoc analysis, long-term follow-up); real world data with new therapies; observational studies; emerging therapies (i.e. CAR-T, multi-target molecules); classical and new treatment optimization for special situations (frailty, advanced age…)…
1.3 Specialized management of specific situations: subglottic stenosis, vascular reconstruction and endovascular intervention, renal transplantation, cutaneous necrotic lesions, pregnancy...
1.4 Disease Assessment: activity, damage, response and remission criteria, imaging...
1.5 Outcomes: remission, relapse, mortality, patient reported outcomes...
1.6 End-organ damage: kidney failure, pulmonary and cardiac fibrosis...
1.7 Comorbidities: cardiovascular risk, frailty, osteoporosis, infection and its prevention, vaccines...
1.8 Pediatric vasculitis
1.9 Rare forms of vasculitis
1.10 Vasculitis -related diseases: polymyalgia rheumatica, IgG4-related disease…
1.11 Infectious vasculitis, vasculitis associated with autoimmune or haematologic disorders.
2. TRANSLATIONAL SCIENCE
2.1 Genetics and epigenetics. Alterations leading to monogenic vasculitis
2.2 Exposome: climate, pollutants, triggering infectious agents...
2.3 Cellular and molecular mechanisms of disease: B cells, T cells, macrophages, eosinophils, neutrophils, endothelial cells, stromal cells, complement, senescent cells...
2.4 Mechanisms of tissue injury: oxidative damage, proteases, apoptosis, extracellular traps…
2.5 Mechanisms of tissue repair: vascular remodelling, fibrosis…
2.6 Biomarkers: diagnosis, prognosis, disease activity, predictors of response...
2.7 Emerging technologies and approaches: organoids, single cell RNA sequencing, spatial transcriptomics, data linkage and machine learning, personalized medicine...
An abstract may be submitted for presentation at the Workshop as one of the following categories:
At the review stage, the Programme Committee may change the presentation type submitted by the author to ensure the continuity of the Workshop programme i.e. oral presentation may be changed to poster presentation. The presenting author will be informed of a change to his/her submitted presentation type at the acceptance notification stage. The decision of the programme committee is definitive.
Abstract acceptance will be in one of the following categories:
Oral Presentation Format:
Presentation specifications will be tailored to the specific Abstract Session. Details will be provided upon acceptance.
Poster Presentation Format:
Authors of accepted poster abstracts will be asked to produce a poster for display at the Workshop. Details of poster specification will be given at time of notification.
Abstract publication only:
In case submissions exceed the available space, some accepted abstracts may be exceptionally selected for publication only.
Accepted abstracts will be published digitally. Abstract publication is a condition of acceptance. All abstracts accepted must abide by guidelines and editorial requests. This may include shortening of abstracts before they are published.
Vasculitis Workshop 2024 Organisers will provide high-quality sessions focused on educational content that is free from commercial influence or bias. Thus, the submitting author of an abstract is requested to declare potential conflicts of interest for all authors during the abstract submission.
All authors must disclose relevant financial relationship(s) at the time of submission.
Please adhere to the following formatting guidelines when preparing abstracts for submission for Vasculitis Workshop 2024. Abstracts which do not adhere to the guidelines will not be reviewed.
Who submits the abstract?
The Presenting Author must submit the abstract and will act as the main point of contact for the abstract with organisers.
Upon successful submission of the abstract a confirmation email will be sent to the Presenting Author. If you have not received a confirmation email, please contact the technical secretariat at:
Type of work and structure:
Research work (Oral or Poster)
Organize oral or poster abstract body content in sections as follows:
Clinical Case Study (Only Poster)
Organise case study/research abstract body content in sections as follows:
All abstracts will go through a blind peer-review carried out by reviewers selected by the Vasculitis Workshop 2024 Programme Committee.
Notification of acceptance or rejection to the programme will be sent to the submitter on 20th December 2023.
Notification of the presentation type will be sent to submitters of accepted abstracts on 8th February 2024.
When notified of acceptance, the Presenting Author is required to accept the offer by registering for the Workshop and paying in full by Monday 15th January 2024.
Written notice must be submitted by Monday, 12th February 2024 at the very latest for all withdrawals and change of presenters. Please contact the scientific secretariat at